TJ Slavin MD

At #ACMGMtg23, we presented a poster on “Prospective Longitudinal Validation of a Breast Cancer Risk Prediction Model in a Cohort of 130,058 Individuals," which was awarded Top Abstract honors! Learn more about MyRisk with RiskScore®: myriad.com/genetic-tests/… @TheACMG

Come join us for colon cancer awareness month with extra special guests! myriad.zoom.us/meeting/regist…

Come join us!

Come join us next week! myriad.zoom.us/meeting/regist…

Come join us and bring your questions! myriad.zoom.us/meeting/regist…

Come join us 1/31 to help kick off Myriad Live in 2023. myriad.zoom.us/meeting/regist…

If you are wondering about the current state of prostate cancer genomics listen to this! healthprofessionalradio.com.au/myriad-genetic…

Come with questions! We will have answers.

Really excited to be heading out soon for #SABCS22. If you’re going to be in attendance stop by @myriadgenetics booth 1001.

@MyriadOncology @myriadgenetics @BeetsWhoTweets

I wanted to put the following invitation on everyone's radar. We will be joined by Bita Nehoray and Tinamarie Bauman as well as a legal expert. Bring your questions! myriad.zoom.us/meeting/regist…

@LGtheCGC @CorpConventions @myriadgenetics It is an SNV and borders on the definition of a SNP. The mean allele frequency though in the population at around 0.5% is lower than a standard SNP definition. However the association with breast cancer as shown is far lower than a standard CHEK2 PV. Glad to have it part of PRS!

More nuggets from @myriadgenetics sponsored ceu lunch session - I love this graphic and have heard @SlavinTj expertly explain the impact of different PVs in CHEK2. Based on the below information i157t related BC risk is best characterized as an SNV. Thoughts? #genechat #NSGC22

Come join us tonight at Nashville underground! #NSGC22

Looking good Rob!

Up next on MyriadLive from #NSGC22 - @KiraDineen & @SlavinTj talk health equity in prenatal at 1 pm CT. Catch it! @GeneticCouns @DNATodayPodcast #genechat @myriadgenetics

Attention #NSGC22 first timers: join Myriad Genetics and @GeneticCouns for the First Time Attendee Reception from 6:00-7:00 p.m. CT. Location: room 101. #GeneChat

Live at #NSGC22 on Friday at 12:15 p.m. CT, don't miss this fireside chat with Myriad Genetics president and CEO, Paul J. Diaz. More information here: fb.me/e/3NT3CckPw

If you are attending #NSGC22, visit the Myriad Genetics booth 307 and learn how genetic insights can help to improve the health and well-being of patients. myriad.com/NSGC #GeneChat @GeneticCouns